Stockscreener 앱 받기
4.47
3.47%
0.15
시간 외 거래:
4.52
0.05
+1.12%
전일 마감가:
$4.32
열려 있는:
$4.26
하루 거래량:
744.29K
Relative Volume:
1.22
시가총액:
$307.75M
수익:
$113.02M
순이익/손실:
$-75.07M
주가수익비율:
-4.2869
EPS:
-1.0427
순현금흐름:
$-47.88M
1주 성능:
+10.92%
1개월 성능:
+49.00%
6개월 성능:
+81.71%
1년 성능:
+59.07%
1일 변동 폭
$4.26
$4.58
1주일 범위
$4.00
$4.58
52주 변동 폭
$2.08
$4.58
Orasure Technologies Inc Stock (OSUR) Company Profile
명칭
Orasure Technologies Inc
전화
(503) 641-6115
주소
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
4.47 | 287.10M | 113.02M | -75.07M | -47.88M | -1.0427 |
ISRG
Intuitive Surgical Inc
|
402.18 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
141.61 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
64.14 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.42 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
186.29 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-03 | 재개 | Evercore ISI | In-line |
| 2021-09-22 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | 개시 | Evercore ISI | Outperform |
| 2020-08-10 | 개시 | Citigroup | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
| 2020-08-07 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | 개시 | Lake Street | Buy |
| 2020-04-21 | 재개 | Stephens | Equal-Weight |
| 2018-10-23 | 재개 | Raymond James | Mkt Perform |
| 2018-07-16 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2017-02-09 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | 재확인 | Mizuho | Buy |
| 2015-05-07 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | 재확인 | Mizuho | Buy |
| 2014-06-12 | 재확인 | Canaccord Genuity | Buy |
| 2014-06-11 | 재확인 | Mizuho | Buy |
| 2012-12-21 | 개시 | Mizuho | Buy |
| 2012-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | 개시 | JMP Securities | Mkt Outperform |
모두보기
Orasure Technologies Inc 주식(OSUR)의 최신 뉴스
OraSure receives FDA clearance for home urine collection kit for STIs - Lehigh Valley Business
Is Taysha Gene Therapies, Inc. (TSHA) A Good Stock To Buy Now? - Yahoo Finance
FDA Clears Home Urine Collection Kit for STI Testing - Conexiant
OraSure Wins FDA Clearance for At-Home STI Collection - TipRanks
OraSure secures FDA clearance for product seen as key to future growth - WFMZ.com
OraSure stock jumps on FDA clearance for at-home STI kit - Investing.com
OraSure stock jumps on FDA clearance for at-home STI kit By Investing.com - Investing.com South Africa
OraSure Technologies (NASDAQ: OSUR) wins FDA clearance for Colli-Pee Dx at-home urine collection kit - Stock Titan
OraSure gets FDA nod for at-home STI urine collection kit By Investing.com - Investing.com Australia
OraSure gets FDA nod for at-home STI urine collection kit - Investing.com India
OraSure receives FDA clearance for at-home STI urine collection kit - StreetInsider
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections - The Manila Times
FDA clears at-home urine kit that lets labs test for 4 STIs by mail - Stock Titan
OraSure Technologies (OSUR) Slips 3.1% as Stock Tests Key Support LevelOvernight Profile - newsline.com
Is Cogent Biosciences, Inc. (COGT) A Good Stock To Buy Now? - Yahoo Finance
OraSure Technologies (OSUR) director receives 46,106-share restricted stock grant - Stock Titan
OraSure (OSUR) director Nancy Gagliano receives 46,106-share stock award - Stock Titan
OraSure Technologies (OSUR) director receives 46,106-share stock grant - Stock Titan
OraSure (OSUR) director John P. Kenny granted 46,106 restricted shares - Stock Titan
Director at OraSure (NASDAQ: OSUR) receives 46,106 restricted shares - Stock Titan
Earnings call transcript: OraSure Technologies Q1 2026 misses earnings and revenue forecasts - Investing.com UK
OraSure Technologies Investors Approve Expanded Stock Plan, Governance Changes - The Globe and Mail
OraSure Technologies (NASDAQ: OSUR) OKs more equity awards and board declassification - Stock Titan
OraSure Technologies Hits New 52-Week High of $4.33, Marking Significant Growth - Markets Mojo
OSUR Q1 2026 Earnings: EPS Miss by 69% Signals Operational HeadwindsFree Cash Flow Trends - newsline.com
OraSure Technologies, Inc.Common Stock (NQ: OSUR - FinancialContent
OraSure Technologies (OSUR) Gains 6%: Testing Resistance as Momentum BuildsEase of Movement - The Legal Advocate
OraSure Technologies Hits New 52-Week High at $4.00 - Markets Mojo
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - Investing.com
OraSure Technologies Hits New 52-Week High at $4.12 - MarketsMojo
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - MarketBeat
OraSure Technologies (OSUR) Gains 3.68% as Stock Approaches Key Resistance LevelNHNL Divergence - The Legal Advocate
OraSure Technologies (OSUR) price target increased by 25.00% to 5.10 - MSN
Insiders Buying OraSure Technologies Might Wish They Invested More, Stock Gains 28% - Moomoo
OraSure Technologies (OSUR) Surges 9%: Key Levels to Watch After Strong MoveBearish Pattern Stocks - The Legal Advocate
OraSure Technologies Inc. (OSUR) Q1 2026 Earnings: Wider-than-Expected Loss Raises Concerns Despite Stock SurgeInvestor Earnings Call - The Legal Advocate
OraSure Technologies (OSUR) Surges 7% as Shares Approach Resistance at $3.45Institutional Volume - newsline.com
Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
OraSure Technologies Independent Director Acquires 195% More Stock - Yahoo Finance
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Insider Buying: Steven Boyd Acquires 75,000 Shares of OraSure Te - GuruFocus
OraSure director Steven Boyd purchases $224,750 in stock By Investing.com - Investing.com India
OraSure director Steven Boyd purchases $224,750 in stock - Investing.com
[Form 3] ORASURE TECHNOLOGIES INC Initial Statement of Beneficial Ownership - Stock Titan
Director at OraSure (NASDAQ: OSUR) awarded 33,661 restricted shares - Stock Titan
Orasure Technologies Inc (OSUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Orasure Technologies Inc 주식 (OSUR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Boyd Steven Kyle | Director |
May 14 '26 |
Buy |
2.99 |
25,000 |
74,750 |
113,462 |
| Boyd Steven Kyle | Director |
May 12 '26 |
Buy |
2.98 |
25,000 |
74,500 |
63,462 |
| McGrath Kenneth J | Chief Financial Officer |
Mar 20 '26 |
Buy |
2.93 |
32,300 |
94,600 |
589,562 |
| EGLINTON MANNER CARRIE | President & CEO |
Mar 20 '26 |
Buy |
2.93 |
32,300 |
94,597 |
2,190,874 |
| McGrath Kenneth J | Chief Financial Officer |
Mar 13 '26 |
Buy |
3.00 |
22,021 |
66,030 |
557,262 |
| EGLINTON MANNER CARRIE | President & CEO |
Mar 13 '26 |
Buy |
3.00 |
22,022 |
66,033 |
2,158,574 |
5.23%
자본화:
|
볼륨(24시간):